Physician profile
Sameh Mohareb
NPI 1609162064
$12,273.46
in general payments reported to CMS, 2019-2025
12 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $156 · 2021: $21.48 · 2022: $28.53 · 2023: $322 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,753.92 | 2019 | |
| Boston Scientific Corporation | $2,422.26 | 2019-2021 | |
| Abbott Laboratories | $1,585.56 | 2019-2023 | Perclose Prostyle |
| Edwards Lifesciences Corporation | $1,086.20 | 2019-2025 | |
| Atricure, INC. | $172.89 | 2023 | |
| Cardiovascular Systems INC. | $129.27 | 2020 | |
| Novartis Pharmaceuticals Corporation | $35.27 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.30 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $23.72 | 2019 | |
| Ge Healthcare | $16.24 | 2021-2022 | |
| Chiesi USA, INC. | $14.41 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Mohareb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.